Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.
- Status
- TERMINATED
- Phase
- PHASE4
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
- Status
- COMPLETED
- Phase
- PHASE3
Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts
- Status
- COMPLETED
- Phase
- PHASE3
A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
- Status
- COMPLETED
- Phase
- PHASE4
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
- Status
- TERMINATED
- Phase
- PHASE3
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
- Status
- COMPLETED
- Phase
- PHASE3
FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
- Status
- WITHDRAWN
- Phase
- NA
Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
- Status
- COMPLETED
- Phase
- NA
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
- Status
- COMPLETED
- Phase
- PHASE3